Nanoveu Limited
NNVUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $7 | $70 | $109 | $567 |
| % Growth | -90.2% | -35.7% | -80.8% | – |
| Cost of Goods Sold | -$4 | $269 | $90 | $323 |
| Gross Profit | $11 | $17 | $19 | $244 |
| % Margin | 153.2% | 24.6% | 17.1% | 43% |
| R&D Expenses | $33 | $12 | $6 | $167 |
| G&A Expenses | $1,951 | $1,389 | $1,502 | $1,812 |
| SG&A Expenses | $1,978 | $1,544 | $1,709 | $1,966 |
| Sales & Mktg Exp. | $26 | $155 | $207 | $154 |
| Other Operating Expenses | $816 | -$76 | -$459 | -$421 |
| Operating Expenses | $2,827 | $1,479 | $1,256 | $1,712 |
| Operating Income | -$2,816 | -$1,462 | -$1,701 | -$1,468 |
| % Margin | -40,972.1% | -2,092.2% | -1,564.6% | -259% |
| Other Income/Exp. Net | -$30 | -$8 | -$119 | -$215 |
| Pre-Tax Income | -$2,846 | -$1,470 | -$1,820 | -$1,684 |
| Tax Expense | $0 | $0 | -$1 | $0 |
| Net Income | -$2,810 | -$2,160 | -$1,821 | -$1,684 |
| % Margin | -40,880.4% | -3,090.6% | -1,675.8% | -297.1% |
| EPS | -0.004 | -0.006 | -0.008 | -0.01 |
| % Growth | 36.2% | 26.6% | 18.6% | – |
| EPS Diluted | -0.004 | -0.006 | -0.008 | -0.01 |
| Weighted Avg Shares Out | 441,660 | 375,334 | 230,338 | 173,507 |
| Weighted Avg Shares Out Dil | 441,660 | 375,334 | 230,338 | 173,507 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7 | $0 | $1 | $0 |
| Interest Expense | $6 | $15 | $120 | $216 |
| Depreciation & Amortization | $67 | $115 | $31 | $37 |
| EBITDA | -$1,691 | -$1,346 | -$1,638 | -$1,432 |
| % Margin | -24,602.2% | -1,925.5% | -1,507.2% | -252.6% |